Política de privacidad      Acceso / Registro

viernes, 23 julio 2021
- Advertisement -

TAG

Multi-Criteria Decision Analysis MCDA

Determination of the Value Contribution of Belantamab Mafodotin (Belamaf; BLENREP®) for the Treatment of Triple-Class Refractory Multiple Myeloma in Spain through Reflective Multi-Criteria Decision...

María Casanova et. al Most patients with multiple myeloma (MM) have an initial response to treatment, however the majority will ultimately progress and develop treatment...

Latest news

- Advertisement -